GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Theragen Etex Co Ltd (XKRX:066700) » Definitions » Shiller PE Ratio

Theragen Etex Co (XKRX:066700) Shiller PE Ratio : 210.97 (As of May. 15, 2025)


View and export this data going back to 2004. Start your Free Trial

What is Theragen Etex Co Shiller PE Ratio?

As of today (2025-05-15), Theragen Etex Co's current share price is ₩3000.00. Theragen Etex Co's E10 for the quarter that ended in Dec. 2024 was ₩14.22. Theragen Etex Co's Shiller PE Ratio for today is 210.97.

The historical rank and industry rank for Theragen Etex Co's Shiller PE Ratio or its related term are showing as below:

XKRX:066700' s Shiller PE Ratio Range Over the Past 10 Years
Min: 17.44   Med: 76.64   Max: 5505.32
Current: 213.1

During the past years, Theragen Etex Co's highest Shiller PE Ratio was 5505.32. The lowest was 17.44. And the median was 76.64.

XKRX:066700's Shiller PE Ratio is ranked worse than
97.52% of 524 companies
in the Drug Manufacturers industry
Industry Median: 24.72 vs XKRX:066700: 213.10

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Theragen Etex Co's adjusted earnings per share data for the three months ended in Dec. 2024 was ₩-1,518.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ₩14.22 for the trailing ten years ended in Dec. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Theragen Etex Co Shiller PE Ratio Historical Data

The historical data trend for Theragen Etex Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theragen Etex Co Shiller PE Ratio Chart

Theragen Etex Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5,498.04 - 65.13 30.52 219.43

Theragen Etex Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.52 28.94 23.25 19.88 219.43

Competitive Comparison of Theragen Etex Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Theragen Etex Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Theragen Etex Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Theragen Etex Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Theragen Etex Co's Shiller PE Ratio falls into.


;
;

Theragen Etex Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Theragen Etex Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=3000.00/14.22
=210.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theragen Etex Co's E10 for the quarter that ended in Dec. 2024 is calculated as:

For example, Theragen Etex Co's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-1518/121.1352*121.1352
=-1,518.000

Current CPI (Dec. 2024) = 121.1352.

Theragen Etex Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201503 15.000 99.721 18.221
201506 5.000 100.051 6.054
201509 7.000 100.111 8.470
201512 -325.000 100.220 -392.824
201603 31.000 100.561 37.342
201606 20.000 100.791 24.037
201609 25.000 101.461 29.848
201612 -6.000 101.561 -7.156
201703 -20.000 102.851 -23.556
201706 -5.000 102.611 -5.903
201709 -27.000 103.491 -31.603
201712 97.000 102.991 114.089
201803 -37.000 104.101 -43.054
201806 26.000 104.130 30.246
201809 -96.000 105.651 -110.070
201812 -231.000 104.351 -268.156
201903 -40.000 104.491 -46.372
201906 161.000 104.881 185.952
201909 2.000 105.200 2.303
201912 1,281.000 105.121 1,476.144
202003 -3.000 105.354 -3.449
202006 -173.000 105.112 -199.372
202009 -35.000 106.198 -39.923
202012 -75.000 105.765 -85.899
202103 -23.000 107.357 -25.952
202106 -53.000 107.579 -59.679
202109 -130.000 108.759 -144.793
202112 -165.000 109.676 -182.239
202203 155.000 111.848 167.870
202206 66.000 114.072 70.086
202209 149.000 114.715 157.339
202212 -72.000 115.179 -75.723
202303 42.000 116.507 43.668
202306 19.000 117.182 19.641
202309 110.000 118.964 112.008
202312 652.000 118.837 664.609
202403 42.000 120.123 42.354
202406 26.000 120.007 26.244
202409 169.000 120.861 169.383
202412 -1,518.000 121.135 -1,518.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Theragen Etex Co  (XKRX:066700) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Theragen Etex Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Theragen Etex Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Theragen Etex Co Business Description

Traded in Other Exchanges
N/A
Address
58, Sandan-ro 68-gil, Danwon-gu, Gyeonggi-do, Ansan-si, KOR
Theragen Etex Co Ltd is a Korea-based company mainly engaged in the manufacturing and selling of finished pharmaceutical products and providing genome sequencing services. It also provides healthcare services. The company's operating segments include its Pharmaceutical business and the Healthcare and Genome Analysis Business. A majority of its revenue is generated from the Pharmaceutical Business which involves the manufacturing and sales of specialized and general medicine along with new drug research and development. The Healthcare and Genome Analysis Business involves DNA sequence analysis, RNA mutation genome analysis and decoding, and the distribution of non-prescription drugs for healthcare purposes. Geographically, the company derives its key revenue from the domestic market.

Theragen Etex Co Headlines

No Headlines